Cargando…
Association of Valproic Acid Use With Post-Myocardial Infarction Heart Failure Development: A Meta-Analysis of Two Retrospective Case–Control Studies
BACKGROUND: Despite advances in treatments, myocardial infarction (MI) remains a significant cause of morbidity and mortality worldwide. Our team has previously shown that valproic acid (VPA) is cardio-protective when administered to rats post-MI. The aim of this study was to investigate the associa...
Autores principales: | English, Joseph D, Tian, Shuo, Wang, Zhong, Luzum, Jasmine A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841513/ https://www.ncbi.nlm.nih.gov/pubmed/36416392 http://dx.doi.org/10.1177/10742484221140303 |
Ejemplares similares
-
HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction
por: Tian, Shuo, et al.
Publicado: (2018) -
Immunopharmacology of Post-Myocardial Infarction and Heart Failure Medications
por: Panahi, Mona, et al.
Publicado: (2018) -
Post-myocardial infarction heart failure dysregulates the bone vascular niche
por: Hoffmann, Jedrzej, et al.
Publicado: (2021) -
Diabetes mellitus exacerbates post‐myocardial infarction heart failure by reducing sarcolipin promoter methylation
por: Liu, Zhongwei, et al.
Publicado: (2020) -
Serum lipidomics reveals phosphatidylethanolamine and phosphatidylcholine disorders in patients with myocardial infarction and post-myocardial infarction-heart failure
por: Rong, Jidong, et al.
Publicado: (2023)